Vagus Nerve Stimulation for Moderate to Severe Rheumatoid Arthritis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mark Richardson, MD PhD
Massachusetts General Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
42 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Arizona Arthritis Ans Rheumatology Research, Pplc
Mesa, Arizona, United States
- Arizona Arthritis Rheumatology & Research, Pllc
Phoenix, Arizona, United States
- Arizona Arthritis & Rheumatology Research, Pllc
Tucson, Arizona, United States
- Medvin Clinical Research
Covina, California, United States
- Inland Rheumatology Clinical Trials
Upland, California, United States
- Medvin Clinical Research
Whittier, California, United States
- the Arthritis & Rheumatology Clinic of Northern Colorado
Fort Collins, Colorado, United States
- Stamford Therapeutics Consortium
Stamford, Connecticut, United States
- Delaware Arthritis
Lewes, Delaware, United States
- Arthritis & Rheumatic Disease Specialties
Aventura, Florida, United States
- Harac Research Corporation
Avon Park, Florida, United States
- Reciomed Clinical Research Network, Inc.
Boynton Beach, Florida, United States
- Bay Area Rheumatology
Clearwater, Florida, United States
- Iris Research and Development
Plantation, Florida, United States
- Augusta University
Augusta, Georgia, United States
- Parris and Associates Rheumatology
Lawrenceville, Georgia, United States
- Northwestern University
Chicago, Illinois, United States
- Willow Rheumatology and Wellness Pllc
Willowbrook, Illinois, United States
- Massachusetts General Hospital Division of Rheumatology, Allergy, and Immunology
Boston, Massachusetts, United States
- June Do, Pc
Lansing, Michigan, United States
- Saint Paul Rheumatology, P.A.
Eagan, Minnesota, United States
- Kansas City Physician Partners
Kansas City, Missouri, United States
- West County Rheumatology
St Louis, Missouri, United States
- Physician Research Collaboration, Llc
Lincoln, Nebraska, United States
- Albuquerque Center for Rheumatology
Albuquerque, New Mexico, United States
- Long Island Regional Arthritis & Osteoporosis Care
Babylon, New York, United States
- Arthritis & Osteoporosis Consultants of the Carolinas
Charleston, North Carolina, United States
- Djl Clinical Research
Charlotte, North Carolina, United States
- Health Research of Oklahoma, Pllc
Oklahoma City, Oklahoma, United States
- Lehigh Valley Health Network
Allentown, Pennsylvania, United States
- University of Pennsylvania Medical Center
Philadelphia, Pennsylvania, United States
- Arthritis & Rheumatology Research Institute, Pllc
Allen, Texas, United States
- Austin Regional Clinic
Austin, Texas, United States
- Central Texas Rheumatology Associates
Austin, Texas, United States
- Tekton Research
Austin, Texas, United States
- Precision Comprehensive Clinical Research Solutions
Colleyville, Texas, United States
- Biopharma Informatic
Houston, Texas, United States
- Southwest Rheumatology Research Llc
Mesquite, Texas, United States
- Clinical Trials of Texas, Inc
San Antonio, Texas, United States
- Annapolis Rheumatology
Fairfax, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 11 Jan 2021
- Primary completion
- 16 May 2024
- Completion
- 31 Oct 2027
- Last update posted
- 14 Apr 2026
- Registered enrollment
- 243
- Registry id
- NCT04539964
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.